Ultragenyx Pharmaceutical Inc. (RARE) has a market capitalization of $2.37B and trades at $24.57. The 52-week range is 18.29-42.37.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.2, Earnings Per Share (EPS) of $-5.83, annual revenue of $673M.
The stock has a beta of 0.25, operates in the Healthcare sector.
